Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Jun 2009 Status changed from not stated to active, no longer recruiting.
- 08 Jun 2009 New trial record.